Posts

Old brains, new tricks: Surprising plasticity in adult ...

Why Adult Plasticity Matters Credit: Hedi Young Why Adult Plasticity Matters Muc...

Carrier receives International Award for Outstanding Le...

Julie Carrier, professor and head of the University of Tennessee Department of B...

Policies favoring high-volume hospitals may disadvantag...

PITTSBURGH, Aug. 17, 2023 – Patients with cancer who live in rural Pennsylvania ...

Racial and ethnic differences in gut microbiome emerge ...

Gut microbiome variation associated with race and ethnicity arises after three m...

Demon Hunting: Physicists confirm 67-year-old predictio...

In 1956, theoretical physicist David Pines predicted that electrons in a solid c...

Study observes sudden acceleration of flow, generates n...

In an experiment on how turbulent boundary layers respond to acceleration in the...

UArizona College of Nursing receives $2.6M HRSA grant t...

The University of Arizona College of Nursing was one of 50 institutions nationwi...

Diagnosis of voice condition from call audio

Overview Credit: COPYRIGHT (C) TOYOHASHI UNIVERSITY OF TECHNOLOGY. ALL RIGHTS RE...

Patient Death Causes 2seventy Bio’s CD33-Targeted CAR-T...

In a recent development, the US Food and Drug Administration (FDA) has placed an...

FDA delays decision on Valneva’s chikungunya vaccine by...

The FDA’s decision on Valneva’s chikungunya virus vaccine candidate, VLA1553, ha...

Leprosy potentially endemic in Central Florida

The proportion of cases found in migrants to Florida has decreased significantly...

Gilead and Tentarix partner on cancer and inflammation ...

Gilead Sciences has entered into partnerships with Tentarix for the development ...

FDA will not meet ahead of bluebird bio’s sickle cell d...

Bluebird bio eyes hattrick of gene therapy approvals, with a PDUFA date for sick...

Diffusion Pharma’s stockholders support merger with EIP...

The merger will be finalised today, transforming the businesses into a single co...

Eyenovia acquires US licencing rights for Formosa’s top...

Eyenovia hopes for near-term revenue from the licencing deal, with APP13007’s PD...

Amicus gears up to launch Pompe disease combination the...

Amicus’ Pombiliti and Opfolda received approval from the UK MHRA through the Inn...